Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments

Register of interests (PDF 274 KB)

Final draft guidance

Final draft guidance (PDF 432 KB)

Committee papers (PDF 3.12 MB)

Public committee slides (PDF 1002 KB)

Equality impact assessment (PDF Version) (PDF 164 KB)

Draft guidance

Appraisal consultation document (PDF version) (PDF 498 KB)

Appraisal consultation document (online commenting)

Committee papers (PDF 12.35 MB)

Public committee slides (PDF 1.99 MB)

Committee meeting

Supporting documentation Register of Interests  (PDF 280 KB)

Final scope (PDF 235 KB)

Final stakeholder list (PDF 169 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 185 KB)

Equality impact assessment (Scoping) (PDF 121 KB)

Draft matrix post referral (PDF 167 KB)

Draft scope post referral (PDF 239 KB)